Anaplastic ependymoma
MONDO:0016700Anaplastic ependymoma is a rare, malignant type of ependymoma that most often arises in the supratentorial region of the brain of children and young adults and that manifests with variable symptoms including headaches, nausea, vision impairment, memory loss and difficulty walking.
Also known as: ependymal tumors, ependymal tumours, WHO grade III ependymal neoplasm, WHO grade III ependymal tumor, WHO grade III ependymal tumour, anaplastic ependymal neoplasm, anaplastic ependymal tumor, anaplastic ependymal tumour
2839 clinical trials for this condition and its sub-types, 7 tagged with Anaplastic ependymoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Anaplastic ependymoma
-
Posterior fossa ependymoma 3 trials
2 sub-types
- Posterior fossa group A ependymoma 2 trials
- Posterior fossa group B ependymoma 0 trials
-
Adult anaplastic ependymoma 1 trial
-
Supratentorial ependymoma 1 trial
3 sub-types
-
Promising targeted therapy for tough brain cancers moves forward
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dos…
Phase 1/2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New proton beam therapy aims to shrink Kids' brain tumors with fewer side effects
Disease control Recruiting nowThis early-stage trial tests a precise type of proton radiation for children with ependymoma, a brain tumor. The therapy is designed to kill cancer cells while reducing damage to healthy brain tissue. About 48 children will take part to see if the treatment is safe and what side …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New pill shows promise in early brain tumor trial
Disease control Recruiting nowThis early-stage study tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and check for side effects. About 102 participants will take the drug once or several times a week.
Phase 1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Tailored tumor testing aims to match kids with best brain cancer therapy
Knowledge-focused Recruiting nowThis study is testing a new approach for children and young adults whose medulloblastoma or ependymoma has come back. Researchers will analyze each person's tumor using drug screening and genetic testing to create a personalized treatment plan. The goal is to find the most effect…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC